Algo version: 0.98b
SABS is listed at the NASDAQ Exchange
SABS [SABS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is SABS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for SAB Biotherapeutics Inc 10 years ago, but if you had invested on Tuesday 9th of February 2021 when the price was $101.50, you would have made a loss of $-98.44 per share or -96.99%

No, the average daily trading liquidity for SAB Biotherapeutics Inc is $152 983 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

SAB Biotherapeutics Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for SAB Biotherapeutics Inc to be medium [0.7 out of 1]